EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Shape-Shifting Myeloma: Adaptive Plasticity as a Hallmark of Relapse and Refractoriness

Maria Elisa Nasso, Adele Bottaro, Demetrio Gerace, Sabina Russo, Donato Mannina iD, Alessandro Allegra iD

Cancers · 08.06.2026 · 18 (12) · 1873

DOI: 10.3390/cancers18121873 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 08.06.2026. Verfasst von Maria Elisa Nasso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, Via Consolare Valeria, 98125 Mess…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Relapsed and refractory multiple myeloma remains the principal cause of myeloma-related mortality despite major advances in therapeutic options, including proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and T-cell-based immunotherapies. Conventional resistance models based on linear genetic clonal evolution inadequately explain reversible drug resistance, heterogeneous responses, and relapse after deep remissions. Emerging data from longitudinal genomics, single-cell analyses, and functional studies support a paradigm in which relapsed and refractory multiple myeloma is driven by adaptive plasticity rather than irreversible genetic change alone. Myeloma cells undergo reversible cell state transitions through transcriptional, epigenetic, metabolic, and proteostatic reprogramming, shaped by bone marrow microenvironmental cues and immune pressure. This narrative review integrates current evidence supporting adaptive plasticity as a central driver of therapeutic failure in relapsed and refractory multiple myeloma and discusses clinical and translational implications, highlighting adaptive treatment strategies and approaches targeting phenotypic flexibility to improve durability of response.

Schlagwörter

Stichwörter der Autor:innen

cell state switchingclonal evolutionepigeneticsimmunotherapy resistancemicroenvironmentmultiple myelomarelapsed/refractory diseasetumor plasticity

Autor:innen und Institutionen

  • Hematology Unit, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, Via Consolare Valeria, 98125 Messina, Italy.
  • Hematology Unit, Oncology-Hematology Department, Azienda Ospedaliera Papardo, 98158 Messina, Italy.

ORCID-Profile: Donato Mannina, Alessandro Allegra

Zitieren

APA

Nasso, M. E., Bottaro, A., Gerace, D., Russo, S., Mannina, D., & Allegra, A. (2026). The Shape-Shifting Myeloma: Adaptive Plasticity as a Hallmark of Relapse and Refractoriness. Cancers, 18(12), 1873. https://doi.org/10.3390/cancers18121873

Vancouver

Nasso ME, Bottaro A, Gerace D, Russo S, Mannina D, Allegra A. The Shape-Shifting Myeloma: Adaptive Plasticity as a Hallmark of Relapse and Refractoriness. Cancers. 2026;18(12):1873. doi:10.3390/cancers18121873

BibTeX
@article{Nasso2026,
  author = {Nasso, Maria Elisa and Bottaro, Adele and Gerace, Demetrio and Russo, Sabina and Mannina, Donato and Allegra, Alessandro},
  title = {The Shape-Shifting Myeloma: Adaptive Plasticity as a Hallmark of Relapse and Refractoriness},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1873},
  doi = {10.3390/cancers18121873}
}
Kostenlos starten →